| Dr Steven Joseph Reiss, MD | |
|
3900 Kresge Way, Ste 51, Louisville, KY 40207-4660 | |
| (502) 891-8981 | |
| (502) 891-4548 |
| Full Name | Dr Steven Joseph Reiss |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 42 Years |
| Location | 3900 Kresge Way, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487647616 | NPI | - | NPPES |
| 3113110 | Other | KY | CIGNA - NNIKY |
| 3698196000 | Other | KY | PASSPORT ADVTG - NNIKY |
| P00706057 | Other | KY | RAILROAD MEDICARE - KY |
| 64229834 | Medicaid | KY | |
| 100365890 | Medicaid | IN | |
| 000000604818 | Other | KY | ANTHEM - NNIKY |
| 000023035M | Other | KY | HUMANA - NNIKY |
| 102718 | Other | KY | SIHO - NNIKY |
| 50022670 | Other | KY | PASSPORT - NNIKY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 22983 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Louisville | Louisville, KY | Hospital |
| Baptist Health Floyd | New albany, IN | Hospital |
| Baptist Health Lagrange | La grange, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
| Kentucky Orthopedic Rehabilitation Llc | 0345157293 | 683 |
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
It's a common herb that more than 10 million American women use to ease menopausal symptoms. Its benefits are touted all over the Internet. Yet, the U.S. Food and Drug Administration has not approved it as a drug, and researchers are unsure of its effects on the human body. A University of Missouri-Columbia researcher is hoping to change that.
In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.
Researchers in separate clinical trials found two drugs slow the progression of idiopathic pulmonary fibrosis, a fatal lung disease with no effective treatment or cure, and for which there is currently no therapy approved by the Food and Drug Administration.
Research presented at the European Academy of Dermatology and Venereology in Prague, Czech Republic, suggests that inhibition of the SMAD protein may be a viable therapeutic target in scleroderma patients.
Amgen today announced the creation of a catalog of qualified tools and reagents available to academic institutions to help further research and advance basic discoveries in biology, as well as deepen relationships with academic institutions.
› Verified 8 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740586213 PECOS PAC ID: 5597867184 Enrollment ID: O20070228000503 |
News Archive
It's a common herb that more than 10 million American women use to ease menopausal symptoms. Its benefits are touted all over the Internet. Yet, the U.S. Food and Drug Administration has not approved it as a drug, and researchers are unsure of its effects on the human body. A University of Missouri-Columbia researcher is hoping to change that.
In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.
Researchers in separate clinical trials found two drugs slow the progression of idiopathic pulmonary fibrosis, a fatal lung disease with no effective treatment or cure, and for which there is currently no therapy approved by the Food and Drug Administration.
Research presented at the European Academy of Dermatology and Venereology in Prague, Czech Republic, suggests that inhibition of the SMAD protein may be a viable therapeutic target in scleroderma patients.
Amgen today announced the creation of a catalog of qualified tools and reagents available to academic institutions to help further research and advance basic discoveries in biology, as well as deepen relationships with academic institutions.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven Joseph Reiss, MD Po Box 950248, Louisville, KY 40295-0248 Ph: (502) 489-5730 | Dr Steven Joseph Reiss, MD 3900 Kresge Way, Ste 51, Louisville, KY 40207-4660 Ph: (502) 891-8981 |
News Archive
It's a common herb that more than 10 million American women use to ease menopausal symptoms. Its benefits are touted all over the Internet. Yet, the U.S. Food and Drug Administration has not approved it as a drug, and researchers are unsure of its effects on the human body. A University of Missouri-Columbia researcher is hoping to change that.
In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.
Researchers in separate clinical trials found two drugs slow the progression of idiopathic pulmonary fibrosis, a fatal lung disease with no effective treatment or cure, and for which there is currently no therapy approved by the Food and Drug Administration.
Research presented at the European Academy of Dermatology and Venereology in Prague, Czech Republic, suggests that inhibition of the SMAD protein may be a viable therapeutic target in scleroderma patients.
Amgen today announced the creation of a catalog of qualified tools and reagents available to academic institutions to help further research and advance basic discoveries in biology, as well as deepen relationships with academic institutions.
› Verified 8 days ago
Maxwell Boakye, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 220 Abraham Flexner Way Ste 1200, Louisville, KY 40202 Phone: 502-899-3623 | |
John Joseph Guarnaschelli, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 234 E Gray St, Suite 768, Louisville, KY 40202 Phone: 502-584-4121 Fax: 502-584-6626 | |
Abigail Justine Rao, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4950 Norton Healthcare Blvd Ste 205, Louisville, KY 40241 Phone: 502-394-6390 Fax: 502-394-6388 | |
Dr. Maria Koutourousiou, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 200 Abraham Flexner Way, Se #1200, Louisville, KY 40202 Phone: 502-899-3623 Fax: 502-899-7970 | |
Nathaniel Todnem, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3900 Kresge Way Ste 51, Louisville, KY 40207 Phone: 502-259-5955 | |
Norberto Omar Andaluz, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 220 Abraham Flexner Way Ste 1200, Louisville, KY 40202 Phone: 502-899-3623 Fax: 502-899-7970 | |
Ashley Nicole Higdon, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 401 E Chestnut St Unit 710, Louisville, KY 40202 Phone: 502-583-8303 |